中华普通外科杂志
中華普通外科雜誌
중화보통외과잡지
CHINESE JOURNAL OF GENERAL SURGERY
2011年
7期
543-545
,共3页
张思森%陈雷%冷希圣%张谢夫%邵永孚
張思森%陳雷%冷希聖%張謝伕%邵永孚
장사삼%진뢰%랭희골%장사부%소영부
十二指肠肿瘤%腺癌%胰十二指肠切除术
十二指腸腫瘤%腺癌%胰十二指腸切除術
십이지장종류%선암%이십이지장절제술
Duodenal neoplasms%Adenocarcinoma%Pancreaticoduodenectomy
目的 探讨原发性十二指肠腺癌的诊断和根治术术式选择.方法 对1985-2009年经手术切除、病理证实的89例十二指肠腺癌患者的临床资料进行回顾性分析.结果 十二指肠腺癌发病率低,临床表现缺乏特异性,术前内镜确诊率为93%,胃肠X线气钡造影为90%,磁共振胰胆管造影为82%,B超为42%,MRVCT为70%.肿瘤位于十二指肠第2段占65%.48例行胰十二指肠切除,19例行十二指肠节段切除,切除术后患者5年生存率分别为47%和50%.结论 内镜和X线气钡双重造影是诊断十二指肠腺癌的主要检查方法.早期诊断和根治手术是提高切除率和疗效的主要途径.
目的 探討原髮性十二指腸腺癌的診斷和根治術術式選擇.方法 對1985-2009年經手術切除、病理證實的89例十二指腸腺癌患者的臨床資料進行迴顧性分析.結果 十二指腸腺癌髮病率低,臨床錶現缺乏特異性,術前內鏡確診率為93%,胃腸X線氣鋇造影為90%,磁共振胰膽管造影為82%,B超為42%,MRVCT為70%.腫瘤位于十二指腸第2段佔65%.48例行胰十二指腸切除,19例行十二指腸節段切除,切除術後患者5年生存率分彆為47%和50%.結論 內鏡和X線氣鋇雙重造影是診斷十二指腸腺癌的主要檢查方法.早期診斷和根治手術是提高切除率和療效的主要途徑.
목적 탐토원발성십이지장선암적진단화근치술술식선택.방법 대1985-2009년경수술절제、병리증실적89례십이지장선암환자적림상자료진행회고성분석.결과 십이지장선암발병솔저,림상표현결핍특이성,술전내경학진솔위93%,위장X선기패조영위90%,자공진이담관조영위82%,B초위42%,MRVCT위70%.종류위우십이지장제2단점65%.48례행이십이지장절제,19례행십이지장절단절제,절제술후환자5년생존솔분별위47%화50%.결론 내경화X선기패쌍중조영시진단십이지장선암적주요검사방법.조기진단화근치수술시제고절제솔화료효적주요도경.
Objective To evaluate the preoperative diagnosis and treatment of primary duodenal adenocarcinoma ( PDA). Methods Clinical data of 89 PDA cases undergoing laparotomy from 1985 to 2009 in three hospital in Beijing and Zhengzhou were analyzed retrospectively. Results The prevalence rate of PDA is comparatively low and its clinical manifestations are not specific. The correct diagnostic rate of auxiliary examination were 93% by endoscopy,90% by gastrointestinal X-ray air barium double radiography,82% by MRCP,42% by BUS,70% by CT/MRI. The most common location of the adenocarcinoma(65% ) was at the second portion of the duodenum. Among 67 PDA cases 48 cases underwent pancreatoduodenectomy, 19 cases received segmental deodenectomy. The 5 year's survival rate was 47% and 50% respectively. Conclusions Endoscope and X-ray radiography are mainstays for the diagnosis of PDA. Early diagnosis and radical operation are the key to improve the resection rate and the long term survival.